Navigation Links
Bioniche Reports Fiscal 2008 First Quarter
Date:11/9/2007

-------------------

------------------------------------------------------------

Balance, June 30,

2007 (68,630,615) - 29,109,976

Transition adjustment 134,674 - 134,674

Net loss for the

period (3,812,759) - (3,812,759)

Issued under employee

share ownership plan - - 113,883

Stock-based

compensation - - 84,746

Shares issued to

directors - - 76,502

------------------------------------------------------------

Balance, Sept. 30,

2007 (72,308,700) - 25,707,022

------------------------------------------------------------

------------------------------------------------------------

Bioniche Life Sciences Inc.

NOTES TO INTERIM CONSOLIDATED

FINANCIAL STATEMENTS

September 30, 2007 and 2006 Unaudited

Bioniche Life Sciences Inc.

INTERIM CONSOLIDATED STATEMENTS OF LOSS

(Unaudited)

For the three months ended September 30

2007 2007

$ $

-------------------------------------------------------------------------

REVENUE

Sales 5,904,784 7,744,626

Cost of sales 2,479,305 3,190,845

-------------------------------------------------------------------------

Gross profit 3,425,479 4,553,781

-------------------------------------------------------------------------

EXPENSES

Administration
'/>"/>

SOURCE Bioniche Life Sciences Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Bioniche Responds to Australian Equine Influenza Outbreak
2. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
3. Bioniche Food Safety Vaccine Receives Global Top Honours in Industry Excellence Awards
4. Bioniche Receives Comment from USDA on a Field Trial for E. coli O157:H7 Cattle Vaccine
5. Media Advisory - Bioniche Discusses USDA Comment on E. coli O157:H7 Cattle Vaccine Field Trial
6. Bioniche to Present at Rodman & Renshaw 9th Annual Healthcare Conference
7. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
8. Haemacure Reports Third Quarter 2007 Results
9. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
10. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
11. MDS Reports Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... Aspen, CO (PRWEB) , ... July 07, 2015 ... ... 726 skin cancer screenings at the Aspen Ideas Festival (AIF), identifying 18 possible ... These potential diagnoses must be confirmed with additional testing. , The Aspen Ideas ...
(Date:7/7/2015)... ... July 07, 2015 , ... A June 29th ... that have emerged about Hillary Clinton. Two plastic surgeons consulted by the publication ... than she has in some time and speculate that she might have benefited ...
(Date:7/7/2015)... ... July 07, 2015 , ... Celestix Networks, ... VE and CelestixFederated VA Series virtual appliances. These virtual platforms expand the ... products, which have proven to simplify the on-premises deployment of unified remote access ...
(Date:7/7/2015)... N.J. (PRWEB) , ... July ... ... CTLT), the leading global provider of advanced delivery technologies and development solutions ... signed an exclusive licensing agreement with Excelimmune, Inc. to access its antibody ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... enhance the experience for its patient community using its IDF ePHR, an electronic ... with primary immunodeficiency diseases (PI) to easily track their health information, including symptoms, ...
Breaking Medicine News(10 mins):Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 2Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 3Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 4Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 2Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 4Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3
... prominent roles in a recent study on the cognitive effects ... and end of one season, 22 percent of those students ... and learning skills than expected, as opposed to only 4 ... shortly after the season and we do not know how ...
... May 17 (HealthDay News) -- Parents of young children with ... bed as their child to monitor their condition, but the ... parents and kids, new research finds. In the study, ... General Hospital for Children in Boston examined the sleeping arrangements ...
... for years that when the proteins RalA and RalB are ... However, until this week, no study had explored the effects ... on the path to developing drugs to target these proteins. ... prostate cancer, to shortened survival in squamous cell carcinoma, a ...
... racial and ethnic disparities in breast cancer exist, they are ... assess the extent of tumors before surgery, according to new ... researchers at the 2012 Annual Meeting of the American Society ... that we didn,t see any differences between black and white ...
... ARBOR, Mich. People with bleeding brain aneurysms have ... they receive aggressive emergency treatment from a specialized team ... patients like them every year, according to new guidelines ... and immediately treating this kind of "bleeding stroke", and ...
... -- A new study confirms the widespread belief that athletes ... may hold clues for managing pain in the general population. ... of more than 550 athletes and more than 330 people ... women, and evaluated pain thresholds (the minimum level of intensity ...
Cached Medicine News:Health News:Parents Often Lose Sleep Over Child's Epilepsy, Study Finds 2Health News:Protein RAL associated with aggressive characteristics in prostate, bladder and skin cancers 2Health News:Fox Chase researchers find no disparities in imaging before breast cancer surgery 2Health News:Specialized care by experienced teams cuts death and disability from bleeding brain aneurysms 2Health News:Specialized care by experienced teams cuts death and disability from bleeding brain aneurysms 3Health News:Athletes Really Do Play Through the Pain 2
(Date:7/7/2015)... July 7, 2015 According ... "Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - ... I-131, Alpha Emitters, Brachytherapy - Y-90), by Application ... published by MarketsandMarkets, this report studies the global ... 2015 to 2020. This market is expected to ...
(Date:7/7/2015)... South Korea and FREMONT, Calif. ... of South Korea and Velos, Inc. ... use of Velos eResearch for cancer research nationally throughout ... other research partners. The recent agreement signing was accompanied by ... Seoul , South Korea.  National ...
(Date:7/7/2015)... 2015 Berger & Montague, P.C., a ... firm with one of the largest and most ... Faruqi and Faruqi, LLP in settling three separate ... Pharmaceuticals LP, Cephalon, Inc., and Biogen, Inc., for ... Under the agreements, AstraZeneca will pay the largest ...
Breaking Medicine Technology:Nuclear Medicine/Radiopharmaceuticals Market Worth $6.96 Billion by 2020 2Nuclear Medicine/Radiopharmaceuticals Market Worth $6.96 Billion by 2020 3Nuclear Medicine/Radiopharmaceuticals Market Worth $6.96 Billion by 2020 4National Cancer Center of South Korea and Velos Sign Long-Term Velos eResearch Agreement 2National Cancer Center of South Korea and Velos Sign Long-Term Velos eResearch Agreement 3AstraZeneca, Cephalon, and Biogen Idec to Pay $55.5 Million to Resolve False Claims Act Allegations Made By Whistleblower Ronald Streck 2AstraZeneca, Cephalon, and Biogen Idec to Pay $55.5 Million to Resolve False Claims Act Allegations Made By Whistleblower Ronald Streck 3
... April 29, 2011 Centocor Ortho Biotech Products, L.P., ... Drug Application (NDA) for trabectedin for the treatment of ... based on the U.S. Food and Drug Administration,s (FDA) ... to obtain approval. The NDA was submitted ...
... Phil Hagerman, president and CEO of Diplomat Specialty Pharmacy ... of the Year. The award was announced at ... annual award along with Grant Thornton LLP, WWJ Newsradio 950 ... Hagerman was chosen from among 45 nominees profiled during the ...
Cached Medicine Technology:Centocor Ortho Biotech Products, L.P. Voluntarily Withdraws NDA for Trabectedin 2Diplomat Specialty Pharmacy's Hagerman Named Grant Thornton Leader & Innovator of the Year 2Diplomat Specialty Pharmacy's Hagerman Named Grant Thornton Leader & Innovator of the Year 3